The presumed association between parvovirus B19 infection and subsequent HSV-1 reactivation indicates a potential immunomodulatory effect. This case underscores the importance of a multidisciplinary approach and prompt therapeutic intervention in the case of viral neuro-ophthalmic complications.
Plesníková et al. (2025) studied this question.